Determinants of successful nonthoracotomy cardioverter-defibrillator implantation: experience in 101 patients using two different lead systems

Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

OBJECTIVES. This study was conducted to identify the determinants of successful nonthoracotomy cardioverter-defibrillator implantation. BACKGROUND. Until recently, either median sternotomy or thoracotomy was necessary to implant the electrodes used for internal cardioverter-defibrillator systems. A number of manufacturers have developed nonthoracotomy lead systems comprising two transvenous coil electrodes and a subcutaneous patch electrode. At present, the factors associated with the success or failure of a nonthoracotomy approach are unknown. METHODS. A total of 101 consecutive patients requiring a cardioverter-defibrillator underwent an initial nonthoracotomy approach. Factors associated with successful nonthoracotomy implantation were prospectively determined. RESULTS. A nonthoracotomy system was implanted in 72 (71%) of 101 patients. Twenty-nine patients (29%) required thoracotomy. Univariate predictors of successful nonthoracotomy implantation included smaller cardiac size (p < 0.0001), smaller cardiothoracic ratio (p < 0.0002), QRS duration < 120 ms (p = 0.003), female gender (p = 0.006), ventricular fibrillation as the presenting arrhythmia (p = 0.03) and smaller echocardiographic left ventricular size (p = 0.04). Multivariate predictors included smaller cardiac size (p < 0.002) and female gender (p < 0.007). Total actuarial survival over a mean (+/- SD) follow-up interval of 12 +/- 7 months was 91 +/- 0.03% and was not different in the thoracotomy and nonthoracotomy groups. CONCLUSIONS. A nonthoracotomy cardioverter-defibrillator system can be implanted in a majority of patients. Smaller cardiac size and female gender are associated with a high probability of successful implantation.

This article has been cited by other articles:

				D. A.M.J. Theuns, T. Szili-Torok, and L. J. Jordaens Defibrillation efficacy testing: Long-term follow-up and mortality Europace, January 1, 2005; 7(6): 509 - 515. [Abstract] [Full Text] [PDF]

				A. Oto, A. Yildirir, G. Kabakci, and E. Atalar Inappropriate Shocks Diagnosed by Stored Electrograms of Implantable Cardioverter Defibrillators: Two Case Reports Angiology, May 1, 2000; 51(5): 425 - 430. [Abstract] [PDF]

				A. Pacifico, K. R. Wheelan, N. Nasir, P. J. Wells, T. K. Doyle, S. A. Johnson, and P. D. Henry Long-term Follow-up of Cardioverter-Defibrillator Implanted Under Conscious Sedation in Prepectoral Subfascial Position Circulation, February 18, 1997; 95(4): 946 - 950. [Abstract] [Full Text]

				D. P. Zipes and D. Roberts Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator : A Comparison of Epicardial and Endocardial Lead Systems Circulation, July 1, 1995; 92(1): 59 - 65. [Abstract] [Full Text]

				J. S. Lawton, K. A. Ellenbogen, M. A. Wood, B. S. Stambler, J. A. Spratt, A. S. Wechsler, and R. J. Damiano Jr Clinical experience with nonthoracotomy cardioverter defibrillators Ann. Thorac. Surg., May 1, 1995; 59(5): 1092 - 1099. [Abstract] [PDF]